Switching between GLP-1 medications There are a few reasons why your clinician may suggest switching GLP-1s
This recommendation was based primarily on preventing hypotension (low blood pressure), and secondarily, on preventing the fishy body odor due to increased excretion of trimethylamine
In other cells, various signaling cascades, including activation of MAPK, phospho-inositol-3-phosphate kinase (PI3K), adenylate cyclase and PKC by GLP-1 agonists, mediate the effects of GLP-1R activation on various cellular functions including insulin secretion and biosynthesis, -cell proliferation and neogenesis
Weight loss typically involves a reduction in both fat and lean tissue
To document HFpEF for Bridge eligibility, your medical record should show a confirmed clinical diagnosis with supporting echocardiogram and, in most cases, an ICD-10 code in the I50.30, I50.31, or I50.32 family